Population Bio’s mission is to make drugs safer and more effective. We accelerate the delivery of precision medicine products to patients by discovering disease-relevant genetic biomarkers that enable:

  • Companion diagnostic test development to identify patients at risk of a serious adverse event (SAE) for currently marketed drugs.
  • Drug repurposing (repositioning) for new indications based on genetic subtypes of common diseases.
  • Drug rescue of promising therapies that fail in clinical trials for safety or efficacy.
  • Disease-modifying drug development for novel targets based on genetic discoveries (causal or protective variants).

Population Bio’s CNV Beacon® platform reduces the genome search space for faster, lower cost discovery of disease-relevant genes and variants.

Latest News